Status:

COMPLETED

Neuroimaging Attentional Impairment During Abstinence

Lead Sponsor:

Duke University

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Smoking

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The broad objective of this proposal is to identify functional neuroanatomical correlates of impairments in sustained attention during smoking abstinence. We will measure changes in performance and re...

Detailed Description

Following an extended training period in which performance will become stable, smokers will be tested in the 4 Tesla MRI scanner (GE LX NVi system) 24 hours after quitting smoking, and tested satiated...

Eligibility Criteria

Inclusion

  • smoked an average of 10 cigarettes per day for two years
  • a brand that delivers (by Federal Trade Commission rated yields) at least 0.5 mg nicotine
  • have an expired air carbon monoxide reading of at least 10 ppm.
  • be in general good health
  • Participants with controlled medical conditions (e.g., hypertension) will be considered if treatment is not thought to interfere with fMRI measures or potentially ameliorate smoking withdrawal symptoms

Exclusion

  • Individuals with a major medical condition that would make participation unsafe (e.g., have pacemaker or other metallic implant),
  • uncomfortable (e.g., chronic pain),
  • confound results (e.g., psychiatric condition)
  • suffering from claustrophobia; abnormally afraid of closed-in places will be excluded from participation,
  • Current alcohol or drug abuse,
  • smokeless tobacco use, or use of nicotine replacement therapy or other smoking cessation treatment will also be a basis for exclusion and evaluated via a urine test.

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00692406

Start Date

June 1 2005

End Date

January 1 2009

Last Update

March 28 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University Medical Center

Durham, North Carolina, United States, 27705

Neuroimaging Attentional Impairment During Abstinence | DecenTrialz